WallStSmart

Bloom Energy Corp (BE)vsWest Pharmaceutical Services Inc (WST)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

West Pharmaceutical Services Inc generates 52% more annual revenue ($3.07B vs $2.02B). WST leads profitability with a 16.1% profit margin vs -4.4%. WST appears more attractively valued with a PEG of 2.89. WST earns a higher WallStSmart Score of 55/100 (C-).

BE

Hold

35

out of 100

Grade: F

Growth: 6.7Profit: 3.5Value: 4.0Quality: 5.3
Piotroski: 3/9Altman Z: -0.52

WST

Buy

55

out of 100

Grade: C-

Growth: 4.7Profit: 8.0Value: 4.7Quality: 7.3
Piotroski: 5/9Altman Z: 4.91
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for BE.

WSTSignificantly Overvalued (-256.8%)

Margin of Safety

-256.8%

Fair Value

$68.99

Current Price

$243.35

$174.36 premium

UndervaluedFair: $68.99Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

BE1 strengths · Avg: 10.0/10
Revenue GrowthGrowth
35.9%10/10

Revenue surging 35.9% year-over-year

WST2 strengths · Avg: 9.0/10
Altman Z-ScoreHealth
4.9110/10

Safe zone — low bankruptcy risk

Operating MarginProfitability
21.6%8/10

Strong operational efficiency at 21.6%

Areas to Watch

BE4 concerns · Avg: 2.3/10
Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

PEG RatioValuation
4.272/10

Expensive relative to growth rate

Price/BookValuation
48.5x2/10

Trading at 48.5x book value

Return on EquityProfitability
-12.7%2/10

ROE of -12.7% — below average capital efficiency

WST3 concerns · Avg: 3.3/10
P/E RatioValuation
36.1x4/10

Premium valuation, high expectations priced in

EPS GrowthGrowth
2.1%4/10

2.1% earnings growth

PEG RatioValuation
2.892/10

Expensive relative to growth rate

Comparative Analysis Report

WallStSmart Research

Bull Case : BE

The strongest argument for BE centers on Revenue Growth. Revenue growth of 35.9% demonstrates continued momentum.

Bull Case : WST

The strongest argument for WST centers on Altman Z-Score, Operating Margin. Profitability is solid with margins at 16.1% and operating margin at 21.6%.

Bear Case : BE

The primary concerns for BE are Piotroski F-Score, PEG Ratio, Price/Book.

Bear Case : WST

The primary concerns for WST are P/E Ratio, EPS Growth, PEG Ratio.

Key Dynamics to Monitor

BE profiles as a hypergrowth stock while WST is a mature play — different risk/reward profiles.

BE carries more volatility with a beta of 3.18 — expect wider price swings.

BE is growing revenue faster at 35.9% — sustainability is the question.

BE generates stronger free cash flow (398M), providing more financial flexibility.

Bottom Line

WST scores higher overall (55/100 vs 35/100), backed by strong 16.1% margins. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Bloom Energy Corp

INDUSTRIALS · ELECTRICAL EQUIPMENT & PARTS · USA

Bloom Energy Corporation designs, manufactures and sells solid oxide fuel cell systems for on-site power generation in the United States, Japan, China, India, and the Republic of Korea. The company is headquartered in San Jose, California.

West Pharmaceutical Services Inc

HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA

West Pharmaceutical Services, Inc. is a designer and manufacturer of injectable pharmaceutical packaging and delivery systems. The company is headquartered in Exton, Pennsylvania.

Want to dig deeper into these stocks?